A Randomized, Double-blind, Phase 3 Study of Vorasidenib Versus Placebo in Patients with Mutant IDH1/2 Diffuse Glioma (INDIGO): Analysis of Health-related Quality of Life, Neurocognition and Seizures

Author:Peters, Katherine   Mellinghoff, Ingo   Van Den Bent, Martin   Blumenthal, Deborah   Touat, Mehdi   Clarke, Jennifer   Mendez, Joe   Yust-Katz, Shlomit   Mason, Warren   Ducray, Francois   Umemura, Yoshie   Nabors, Burt   Holdhoff, Matthias   Hottinger, Andreas   Arakawa, Yoshiki   Sepúlveda, Juan   Wick, Wolfgang   Soffietti, Riccardo   Perry, James   Giglio, Pierre   De La Fuente, Macarena   Maher, Elizabeth   Bottomley, Andrew   Zhao, Dan   Pandya, Shuchi   Hassan, Islam   Steelman, Lori   Wen, Patrick   Cloughesy, Timothy   

Session Name:PL5: Clinical Trials Plenary Session  

Topic:Neuro-oncology  

Program Number:PL5.003  

Author Institution:Duke University Medical Center, Durham, NC  Memorial Sloan Kettering Cancer Center, New York, NY  Erasmus Medical Center, Rotterdam, Netherlands  Tel Aviv Medical Center, Tel Aviv University, Tel Aviv, Israel  Pitié Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Sorbonne Université, Paris, France  University of California San Francisco, San Francisco, CA  Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT  Davidoff Cancer Center at Rabin Medical Center, Petah Tikva, Israel  Toronto General Hospital, Toronto, ON, Canada  Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Centre de Recherche en Cancérologie de Lyon, Lyon, France  University of Michigan Comprehensive Cancer Center, Ann Arbor, MI  University of Alabama at Birmingham, Birmingham, AL  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD  University Hospital of Lausanne, Lausanne, Switzerland  Kyoto University Graduate School of Medicine, Kyoto, Japan  Hospital Universitario 12 de Octubre, Madrid, Spain  Universitätsklinikum Heidelberg, Heidelberg, Germany  University of Turin, Turin, Italy  Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada  The Ohio State University Wexner Medical Center, Columbus, OH  Sylvester Comprehensive Cancer Center and Department of Neurology, University of Miami, Miami, FL  University of Texas Southwestern Medical Center, Dallas, TX  Bottomley Consultants, Overijse, Belgium  Servier Pharmaceuticals, Boston, MA  Dana-Farber Cancer Institute, Boston, MA  University of California Los Angeles, Los Angeles, CA  

Childhood Onset Amyotrophic Lateral Sclerosis Associated with SPTLC2 Gain-of-Function Pathogenic Variants: Clinical, Genetic, and Biochemical Insights

Author:Orbach, Rotem   Syeda, Safoora   Mohassel, Payam   Dohrn, Maike   Lone, Museer A.   Donkervoort, Sandra   Foley, A. Reghan   Beijer, Danique   Bayraktar, Elif   Oflazer, Piraye   Munot, Pinki   Rose, Aubrey   Lyons, Michael   Louie, Raymond   Gable, Kenneth   Franca, Marcondes C.   Galarza-Brito, Juan E.   Eckenweiler, Matthias   Asamoah, Alexander   Majumdar, Anirban   Shieh, Perry   Schumann, Anke   Gupta, Sita D.   Lakhotia, Arpita   Jackson, Kelly   Chao, Kathrine R.   Winder, Thomas   Catapano, Francesco   Feng, Lucy   Kirschner, Janbernd   Chen, Sitong   Danzi, Matt   Synofzik, Matthis   Muntoni, Francesco   Basak, A. Nazli   Dunn, Teresa M.   Hornemann, Thorsten   Zuchner, Stephan   Bonnemann, Carsten   

Session Name:P4: Child Neurology and Developmental Neurology: Pediatric Neuromuscular  

Topic:Child Neurology and Developmental Neurology  

Program Number:P4.001  

Author Institution:NINDS/NIH, Bethesda, MD  University of Miami, MIAMI, FL  Institute of Clinical Chemistry, University of Zurich, Zurich, Switzerland  Koç University, Istanbul, Turkey  UCL Institute of Child Health, London, United Kingdom  Greenwood Genetic Center, Greenwood, SC  Uniformed Services University of Health Sciences, Bethesda, MD  University of Campinas, Sao Paulo, Brazil  Hospital Pablo Arturo Suarez, Quito, Ecuador  University of Freiburg, Freiburg, Germany  University of Louisville, Louisville, KY  Bristol Children's Hospital, Bristol, United Kingdom  University of California Los Angeles, Los Angeles, CA  University of Louisville/Norton Children Medical Group, Louisville, KY  Broad Institute of MIT and Harvard, Cambridge, MA  Invitae Corp., Marshfield, WI  Hertie-Institute for Clinical Brain Research, Tubingen, Germany  

Antiseizure Medications in Post-stroke Seizures: A Systematic Review and Network Meta-analysis

Author:Misra, Shubham   Dawson, Jesse   Kwan, Patrick   Kasner, Scott E.   Grotta, James C.   Larsson, David   Tanaka, Tomotaka   Zaveri, Hitten   Wang, Selena   Khan, Erum I.   Funaro, Melissa   Perla, Sravan   Dev, Priya   Hussain, Taimoor   Liebeskind, David S.   Yasuda, Clarissa   Elshahat, Amr   Hitawala, Gazala   Wang, Ethan   Kitagawa, Rachel   Pathak, Abhishek   Zhao, Yize   Scalzo, Fabien   Ihara, Masafumi   Zelano, Johan   Sunnerhagen, Katharina   Walters, Matthew   Jette, Nathalie   Quinn, Terry   Mishra, Nishant   

Session Name:P8: Epilepsy/Clinical Neurophysiology (EEG): Anti-seizure Medications: Clinical Trials and Outcomes  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:P8.012  

Author Institution:Yale University, New Haven, CT  University of Glasgow, Glasgow, United Kingdom  Monash University, Melbourne, Australia  The University of Pennsylvania, Philadelphia, PA  UTHealth Houston, Houston, TX  Sahlgrenska University Hospital, Gothenburg, Sweden  National Cerebral and Cardiovascular Center, Osaka, Japan  The University of Alabama, Tuscaloosa, AL  Banaras Hindu University, Varanasi, India  University of California Los Angeles, Los Angeles, CA  University of Campinas, Campinas, Brazil  Pepperdine University, Malibu, CA  National Cerebral and Cardiovascular Center, Suita, Japan  University of Gothenburg, Gothenburg, Sweden  University of Calgary, Calgary, AB, Canada  

Biomarkers in Extracellular Vesicles from Bodily Fluids for Parkinsonian Disorders: A Systematic Review & Diagnostic Meta-analysis